| 1. |
Mosca R, van de Vlekkert D, Campos Y, et al. Conventional and unconventional therapeutic strategies for sialidosis type I[J]. J Clin Med, 2020, 9(3): 695. DOI: 10.3390/jcm9030695.
|
| 2. |
Fan SP, Lee NC, Lin CH. Clinical and electrophysiological characteristics of a type 1 sialidosis patient with a novel deletion mutation in NEU1 gene[J]. J Formos Med Assoc, 2020, 119(3): 406-412. DOI: 10.1016j.jfma.2019.07.017.
|
| 3. |
Vial F, McGurrin P, Attaripour S, et al. Myoclonus generators in sialidosis[J]. Clin Neurophysiol Pract, 2022, 7: 169-173. DOI: 10.1016/j.cnp.2022.05.004.
|
| 4. |
Seol B, Kim YD, Cho YS. Modeling sialidosis with neural precursor cells derived from patient-derived induced pluripotent stem cells[J]. Int J Mol Sci, 2021, 22(9): 4386. DOI: 10.3390/ijms22094386.
|
| 5. |
呂瑞娟, 李陶然, 金麗日, 等. 來自不同地域的Ⅰ型SD患者的臨床和遺傳特征研究[C/OL]//中國抗癲癇協會腦電圖與神經電生理分會. 第七屆CAAE腦電圖與神經電生理大會會刊, 南京, 2020: 131-132.Lyu RJ, Li TR, Jin LR, et al. Clinical and genetic characteristics of patients with type I SD from different regions[C/OL]// Electroencephalogram and Neuroelectrophysiology Society of China Association Against Epilepsy. The 7th CAAE national EEG& Neurophysiology Conference, Nanjing, 2020: 131-132.
|
| 6. |
Khan A, Sergi C. Sialidosis: a review of morphology and molecular biology of a rare pediatric disorder[J]. Diagnostics (Basel), 2018, 8(2): 29. DOI: 10.3390/diagnostics8020029.
|
| 7. |
Caciotti A, Melani F, Tonin R, et al. Type I sialidosis, a normosomatic lysosomal disease, in the differential diagnosis of late-onset ataxia and myoclonus: an overview[J/OL]. Mol Genet Metab, 2020, 129(2): 47-58[2019-10-31]. https://pubmed.ncbi.nlm.nih.gov/31711734/. DOI: 10.1016/j.ymgme.2019.09.005.
|
| 8. |
Ahn JH, Kim AR, Lee C, et al. Type 1 sialidosis patient with a novel deletion mutation in the NEU1 gene: case report and literature review[J]. Cerebellum, 2019, 18(3): 659-664. DOI: 10.1007/s12311-019-1005-2.
|
| 9. |
Zou W, Wang X, Tian G. Fundus autofluorescence and optical coherence tomography of a macular cherry-red spot in a case report of sialidosis[J]. BMC Ophthalmol, 2016, 16: 30. DOI: 10.1186/s12886-016-0201-9.
|
| 10. |
Michalewska Z, Gajos A, Michalewski J, et al. Spectral optical coherence tomography in a patient with type I sialidosis[J]. Med Sci Monit, 2011, 17(10): 129-131. DOI: 10.12659/msm.881971.
|
| 11. |
Tripathy K, Patel BC. Cherry Red Spot[M]. Treasure Island (FL): StatPearls Publishing, 2023.
|
| 12. |
彭春霞, 余繼鋒, 任曉暾, 等. 56例中國嬰幼兒型神經節苷脂沉積癥患兒眼部與神經系統表現相關性分析[J]. 中華眼底病雜志, 2021, 37(5): 352-357. DOI: 10.3760/cma.j.cn511434-20210331-00164.Peng CX, Yu JF, Ren XT, et al. Correlation analysis of eye and neurological manifestations in 56 children with infantile gangliosideosis in China[J]. Chin J Ocul Fundus Dis, 2021, 37(5): 352-357. DOI: 10.3760/cma.j.cn511434-20210331-00164.
|
| 13. |
Lai SC, Chen RS, Wu Chou YH, et al. A longitudinal study of Taiwanese sialidosis type 1: an insight into the concept of cherry‐red spot myoclonus syndrome[J]. Eur J Neurol, 2009, 16: 912-919. DOI: 10.1111/j.1468-1331.2009.02622.x.
|
| 14. |
Lv RJ, Li TR, Zhang YD, et al. Clinical and genetic characteristics of type I sialidosis patients in mainland China[J]. Ann Clin Transl Neurol, 2020, 7(6): 911-923. DOI: 10.1002/acn3.51058.
|
| 15. |
Han X, Wu S, Wang M, et al. Genetic and clinical characterization of mainland Chinese patients with sialidosis type 1[J/OL]. Mol Genet Genomic Med, 2020, 8(8): e1316[2020-05-26]. https://pubmed.ncbi.nlm.nih.gov/32453490/. DOI: 10.1002/mgg3.1316.
|
| 16. |
Uchihara T, Ohashi K, Kitagawa M, et al. Sialidosis type I carrying V217M/G243R mutations in lysosomal sialidase: an autopsy study demonstrating terminal sialic acid in lysosomal lamellar inclusions and cerebellar dysplasia[J]. Acta Neuropathol, 2010, 119(1): 135-145. DOI: 10.1007/s00401-009-0544-x.
|
